NCT03076255 2025-10-15
Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors
Thomas Jefferson University
Phase NA Completed
Clinical Trials
8 trialsNCT01817751 2024-07-17
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Virginia Commonwealth University
Phase 2 Completed
NCT00928226 2024-01-30
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Stanford University
Phase NA Completed
NCT02313272 2023-10-23
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT02343549 2022-11-03
A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01120639 2021-08-06
Tx-Treatment
Stanford University
Phase 1/2 Completed
NCT00360828 2017-03-23
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00964743 2013-09-09
Depocyt® With Sorafenib in Neoplastic Meningitis
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated